Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

127.43
Delayed Data
As of Jul 31
 +1.97 / +1.57%
Today’s Change
52.35
Today|||52-Week Range
140.00
+31.37%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sanofi
Buy1/26/2015647,448$95.00$61.5M+33.85%
Sanofi
Buy1/22/2015196,251$93.17$18.3M+36.77%
Sharp Phillip Allen
Director
Sale10/13/2014110,000$85.00$9.4M+47.01%
Sanofi
Buy1/29/201597,118$95.00$9.2M+36.39%
Greene Barry E
President & Chief Operating Officer
Sale5/26/201567,379$125.00$8.4M-0.34%
Maraganore John M
Chief Executive Officer
Sale9/18/201437,872$79.23$3.0M+63.00%
Starr Kevin Paul
Director
Sale9/25/201434,201$77.13$2.6M+64.43%
Starr Kevin Paul
Director
Sale9/24/201428,925$79.45$2.3M+61.26%
Maraganore John M
Chief Executive Officer
Sale9/17/201423,286$76.54$1.8M+64.02%
Greene Barry E
President & Chief Operating Officer
Sale11/17/201418,059$89.11$1.6M+43.21%
Page of 13